ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

PCI Files Application For Research Base COP

September 9, 1994

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013